List of Tables
    Table 1. Pirfenidone CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028
    Table 2. Pirfenidone Market Trends
    Table 3. Pirfenidone Market Drivers
    Table 4. Pirfenidone Market Challenges
    Table 5. Pirfenidone Market Restraints
    Table 6. Global Pirfenidone Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 7. United States Pirfenidone Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 8. Global Pirfenidone Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 9. United States Pirfenidone Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 10. Top Pirfenidone Manufacturers in Global Market, Ranking by Revenue (2021)
    Table 11. Global Pirfenidone Revenue by Manufacturer, (US$ Million), 2017-2022
    Table 12. Global Pirfenidone Revenue Share by Manufacturer, 2017-2022
    Table 13. Global Pirfenidone Sales by Manufacturer, (K Pcs), 2017-2022
    Table 14. Global Pirfenidone Sales Share by Manufacturer, 2017-2022
    Table 15. Global Pirfenidone Price by Manufacturer (2017-2022) & (USD/Pcs)
    Table 16. Global Pirfenidone Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 17. Global Pirfenidone by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pirfenidone as of 2021)
    Table 18. Top Players of Pirfenidone in Global Market, Headquarters and Distribution of Producing Region
    Table 19. Manufacturers Pirfenidone Product Type
    Table 20. Date of International Manufacturers Enter into Pirfenidone Market
    Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 22. Top Pirfenidone Players in United States Market, Ranking by Revenue (2021)
    Table 23. United States Pirfenidone Revenue by Players, (US$ Million), 2020, 2021 & 2022
    Table 24. United States Pirfenidone Revenue Share by Players, 2020, 2021 & 2022
    Table 25. United States Pirfenidone Sales by Players, (K Pcs), 2020, 2021 & 2022
    Table 26. United States Pirfenidone Sales Share by Players, 2020, 2021 & 2022
    Table 27. Global Pirfenidone Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
    Table 28. Global Pirfenidone Sales in Volume by Region (2017-2022) & (K Pcs)
    Table 29. Global Pirfenidone Sales in Volume Forecast by Region (2023-2028) & (K Pcs)
    Table 30. Global Pirfenidone Sales in Value by Region (2017-2022) & (US$ Million)
    Table 31. Global Pirfenidone Sales in Value Forecast by Region (2023-2028) & (US$ Million)
    Table 32. North America Pirfenidone Sales in Volume by Country (2017-2028) & (K Pcs)
    Table 33. North America Pirfenidone Sales in Value by Country (2017-2028) & (US$ Million)
    Table 34. Asia Pacific Pirfenidone Sales in Volume by Region (2017-2028) & (K Pcs)
    Table 35. Asia Pacific Pirfenidone Sales in Value by Region (2017-2028) & (US$ Million)
    Table 36. Europe Pirfenidone Sales in Volume by Country (2017-2028) & (K Pcs)
    Table 37. Europe Pirfenidone Sales in Value by Country (2017-2028) & (US$ Million)
    Table 38. Latin America Pirfenidone Sales in Volume by Country (2017-2028) & (K Pcs)
    Table 39. Latin Americaa Pirfenidone Sales in Value by Country (2017-2028) & (US$ Million)
    Table 40. Middle East and Africa Pirfenidone Sales in Volume by Country (2017-2028) & (K Pcs)
    Table 41. Middle East and Africa Pirfenidone Sales in Value by Country (2017-2028) & (US$ Million)
    Table 42. Genentech (Roche) Corporation Information
    Table 43. Genentech (Roche) Description and Business Overview
    Table 44. Genentech (Roche) Pirfenidone Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 45. Genentech (Roche) Pirfenidone Product
    Table 46. Genentech (Roche) Recent Development
    Table 47. Shionogi Corporation Information
    Table 48. Shionogi Description and Business Overview
    Table 49. Shionogi Pirfenidone Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 50. Shionogi Product
    Table 51. Shionogi Recent Development
    Table 52. GNI Group Corporation Information
    Table 53. GNI Group Description and Business Overview
    Table 54. GNI Group Pirfenidone Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 55. GNI Group Product
    Table 56. GNI Group Recent Development
    Table 57. Beijing Continent Corporation Information
    Table 58. Beijing Continent Description and Business Overview
    Table 59. Beijing Continent Pirfenidone Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 60. Beijing Continent Product
    Table 61. Beijing Continent Recent Development
    Table 62. Cipla Corporation Information
    Table 63. Cipla Description and Business Overview
    Table 64. Cipla Pirfenidone Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 65. Cipla Product
    Table 66. Cipla Recent Development
    Table 67. Lupin Ltd Corporation Information
    Table 68. Lupin Ltd Description and Business Overview
    Table 69. Lupin Ltd Pirfenidone Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 70. Lupin Ltd Product
    Table 71. Lupin Ltd Recent Development
    Table 72. Zydus Cadila Corporation Information
    Table 73. Zydus Cadila Description and Business Overview
    Table 74. Zydus Cadila Pirfenidone Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 75. Zydus Cadila Product
    Table 76. Zydus Cadila Recent Development
    Table 77. Glenmark Pharmaceuticals Corporation Information
    Table 78. Glenmark Pharmaceuticals Description and Business Overview
    Table 79. Glenmark Pharmaceuticals Pirfenidone Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 80. Glenmark Pharmaceuticals Product
    Table 81. Glenmark Pharmaceuticals Recent Development
    Table 82. Koye Pharmaceuticals Corporation Information
    Table 83. Koye Pharmaceuticals Description and Business Overview
    Table 84. Koye Pharmaceuticals Pirfenidone Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 85. Koye Pharmaceuticals Product
    Table 86. Koye Pharmaceuticals Recent Development
    Table 87. MSN Laboratories Corporation Information
    Table 88. MSN Laboratories Description and Business Overview
    Table 89. MSN Laboratories Pirfenidone Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 90. MSN Laboratories Product
    Table 91. MSN Laboratories Recent Development
    Table 92. Wockhardt Corporation Information
    Table 93. Wockhardt Description and Business Overview
    Table 94. Wockhardt Pirfenidone Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 95. Wockhardt Product
    Table 96. Wockhardt Recent Development
    Table 97. Incepta Pharmaceuticals Corporation Information
    Table 98. Incepta Pharmaceuticals Description and Business Overview
    Table 99. Incepta Pharmaceuticals Pirfenidone Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 100. Incepta Pharmaceuticals Product
    Table 101. Incepta Pharmaceuticals Recent Development
    Table 102. Unimed Unihealth Corporation Information
    Table 103. Unimed Unihealth Description and Business Overview
    Table 104. Unimed Unihealth Pirfenidone Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 105. Unimed Unihealth Product
    Table 106. Unimed Unihealth Recent Development
    Table 107. Key Raw Materials Lists
    Table 108. Raw Materials Key Suppliers Lists
    Table 109. Pirfenidone Customers List
    Table 110. Pirfenidone Distributors List
    Table 111. Research Programs/Design for This Report
    Table 112. Key Data Information from Secondary Sources
    Table 113. Key Data Information from Primary Sources
List of Figures
    Figure 1. Pirfenidone Product Picture
    Figure 2. Global Pirfenidone Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 3. Global Pirfenidone Market Size 2017-2028 (US$ Million)
    Figure 4. Global Pirfenidone Sales 2017-2028 (K Pcs)
    Figure 5. United States Pirfenidone Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 6. United States Pirfenidone Market Size 2017-2028 (US$ Million)
    Figure 7. United States Pirfenidone Sales 2017-2028 (K Pcs)
    Figure 8. United States Pirfenidone Market Share in Global, in Value (US$ Million) 2017-2028
    Figure 9. United States Pirfenidone Market Share in Global, in Volume (K Pcs) 2017-2028
    Figure 10. Pirfenidone Report Years Considered
    Figure 11. Product Picture of Tablet
    Figure 12. Product Picture of Capsule
    Figure 13. Product Picture of Other
    Figure 14. Global Pirfenidone Market Share by Type in 2022 & 2028
    Figure 15. Global Pirfenidone Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 16. Global Pirfenidone Sales Market Share in Value by Type (2017-2028)
    Figure 17. Global Pirfenidone Sales by Type (2017-2028) & (K Pcs)
    Figure 18. Global Pirfenidone Sales Market Share in Volume by Type (2017-2028)
    Figure 19. Global Pirfenidone Price by Type (2017-2028) & (USD/Pcs)
    Figure 20. United States Pirfenidone Market Share by Type in 2022 & 2028
    Figure 21. United States Pirfenidone Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 22. United States Pirfenidone Sales Market Share in Value by Type (2017-2028)
    Figure 23. United States Pirfenidone Sales by Type (2017-2028) & (K Pcs)
    Figure 24. United States Pirfenidone Sales Market Share in Volume by Type (2017-2028)
    Figure 25. United States Pirfenidone Price by Type (2017-2028) & (USD/Pcs)
    Figure 26. Product Picture of Mild Idiopathic Pulmonary Fibrosis
    Figure 27. Product Picture of Moderate Idiopathic Pulmonary Fibrosis
    Figure 28. Product Picture of Other
    Figure 29. Global Pirfenidone Market Share by Application in 2022 & 2028
    Figure 30. Global Pirfenidone Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 31. Global Pirfenidone Sales Market Share in Value by Application (2017-2028)
    Figure 32. Global Pirfenidone Sales by Application (2017-2028) & (K Pcs)
    Figure 33. Global Pirfenidone Sales Market Share in Volume by Application (2017-2028)
    Figure 34. Global Pirfenidone Price by Application (2017-2028) & (USD/Pcs)
    Figure 35. United States Pirfenidone Market Share by Application in 2022 & 2028
    Figure 36. United States Pirfenidone Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 37. United States Pirfenidone Sales Market Share in Value by Application (2017-2028)
    Figure 38. United States Pirfenidone Sales by Application (2017-2028) & (K Pcs)
    Figure 39. United States Pirfenidone Sales Market Share in Volume by Application (2017-2028)
    Figure 40. United States Pirfenidone Price by Application (2017-2028) & (USD/Pcs)
    Figure 41. North America Pirfenidone Sales in Volume Growth Rate 2017-2028 (K Pcs)
    Figure 42. North America Pirfenidone Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 43. U.S. Pirfenidone Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 44. Canada Pirfenidone Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 45. Europe Pirfenidone Sales in Volume Growth Rate 2017-2028 (K Pcs)
    Figure 46. Europe Pirfenidone Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 47. Germany Pirfenidone Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 48. France Pirfenidone Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 49. U.K. Pirfenidone Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 50. Italy Pirfenidone Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 51. Russia Pirfenidone Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 52. Asia-Pacific Pirfenidone Sales in Volume Growth Rate 2017-2028 (K Pcs)
    Figure 53. Asia-Pacific Pirfenidone Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 54. China Pirfenidone Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 55. Japan Pirfenidone Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 56. South Korea Pirfenidone Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 57. India Pirfenidone Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 58. Australia Pirfenidone Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 59. Taiwan Pirfenidone Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 60. Indonesia Pirfenidone Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 61. Thailand Pirfenidone Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 62. Malaysia Pirfenidone Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 63. Philippines Pirfenidone Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 64. Latin America Pirfenidone Sales in Volume Growth Rate 2017-2028 (K Pcs)
    Figure 65. Latin America Pirfenidone Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 66. Mexico Pirfenidone Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 67. Brazil Pirfenidone Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 68. Argentina Pirfenidone Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 69. Middle East & Africa Pirfenidone Sales in Volume Growth Rate 2017-2028 (K Pcs)
    Figure 70. Middle East & Africa Pirfenidone Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 71. Turkey Pirfenidone Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 72. Saudi Arabia Pirfenidone Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 73. U.A.E Pirfenidone Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 74. Pirfenidone Value Chain
    Figure 75. Pirfenidone Production Process
    Figure 76. Channels of Distribution
    Figure 77. Distributors Profiles
    Figure 78. Bottom-up and Top-down Approaches for This Report
    Figure 79. Data Triangulation
    Figure 80. Key Executives Interviewed